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Abstract
Purpose :
Nanophotoswitches (NPSs) ofer a new tool for optical
simulation of neuronal activity, in vitro and potentially in vivo. Our
group previously reported a ruthenium bipyridine-based NPS (Rubpy-
C17) that, after injection into the eyes of photoreceptor degenerated
blind rats, elicited electrical activity in the contralateral superior
colliculus upon light exposure. Compared with the ruthenium
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complexes, the family of iridium complexes has been more widely used
in clinics, owing to its biosafety profle. We have thus synthesized and
tesed Irbpy-C17, an analog of Rubpy-C17 with the ruthenium core
replaced by iridium.
Methods :
Rubpy molecules can be visualized by their luminescence
upon visible wavelength illumination. To examine membrane
incorporation, fuorescence imaging of HEK cells was obtained after
incubation with Irbpy-C17. Activity of Irbpy-C17 was sudied by MEA
recording from wholemount retina after intravitreal injection. The tes
molecules were adminisered into the vitreous of blind RCS rats at the
concentration of 200 µM. Animals were kept in dark after injection until
the surgical dissection of retina. Acutely isolated retina was mounted on
the MEA with the ganglion cell layer facing down to capture the spiking
activity in response to light simuli.
Results :
Irbpy-C17 exhibited good membrane incorporation similar to
that of Rubpy-C17. Interesingly, despite that Irbpy-C17 elicited minimal
light response initially, subsequent application of synaptic blocker
cocktail that pharmacologically isolated RGCs subsantially enhanced
the light activation of RGCs (1.8 ± 0.3 fold increase in spike frequency).
In comparison with the 3-hour incubation between injection and
dissection, prolonged 24-hour incubation led to a more pronounced 2.5
± 0.5 fold increase in spike frequency.
Conclusions :
Our data sugges that Irbpy-C17 may act on multiple
components of the retinal neural circuitry that could suppress its direct
action on RGCs via synaptic transmission. These molecules
intravitreally adminisered remain sable and active in the ocular
environment up to at leas one day pos injection. These data will
prompt us to further sudy the iridium complexes in parallel with the
ruthenium counterparts, particularly for the underlying mechanism of
their diferential behavior. The NPSs obviates the need for gene
manipulation or toxic UV illumination, highlighting its potential in
generating high-acuity proshetic vision in the blind.
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